Mirafast Soft Chews Bar, Chewable
NDC Package 11523-0159-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Mirafast Soft Chews (magnesium hydroxide) bars is a medication used for a short time to treat occasional constipation. This formulation utilizes a bar, chewable delivery system. Marketed by Bayer Healthcare Llc., this product is identified by NDC 11523-0159 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
11523-0159-1
Package Description
30 POUCH in 1 CARTON / 1 BAR, CHEWABLE in 1 POUCH
Product Code
11523-0159
11-Digit Billing Format
11523015901
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Mirafast Soft Chews
Non-Proprietary Name
Magnesium Hydroxide
Substance Name
Magnesium Hydroxide
Dosage Form
Bar, Chewable - A solid dosage form usually in the form of a rectangle that is meant to be chewed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
MAGNESIUM HYDROXIDE 1200 mg/1
Pharmacologic Class
Usage Information
This medication is used for a short time to treat occasional constipation. It is a laxative (osmotic-type) that is thought to work by drawing water into the intestines, an effect that helps to cause movement of the intestines. This medication is also used to treat symptoms caused by too much stomach acid such as heartburn, upset stomach, or indigestion. It is an antacid that works by lowering the amount of acid in the stomach.

Regulatory & Marketing

Labeler Name
Bayer Healthcare Llc.
Product Type
Human Otc Drug
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-17-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 11523-0159-1 identifies a specific commercial package of 30 pouch in 1 carton / 1 bar, chewable in 1 pouch of Mirafast Soft Chews, a human over the counter drug labeled by Bayer Healthcare Llc.. This bar, chewable is formulated for oral use and contains magnesium hydroxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bayer Healthcare Llc. on February 17, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used for a short time to treat occasional constipation. It is a laxative (osmotic-type) that is thought to work by drawing water into the intestines, an effect that helps to cause movement of the intestines. This medication is also used to treat symptoms caused by too much stomach acid such as heartburn, upset stomach, or indigestion. It is an antacid that works by lowering the amount of acid in the stomach.

How is this Bayer Healthcare Llc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 11523015901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
11523-0159-1
11-Digit CMS (5-4-2)
11523-0159-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.